subscribeSubscribe
Cranbury Pharmaceuticals Receives FDA Approval For Generic Emflaza

Cranbury Pharmaceuticals Receives FDA Approval For Generic Emflaza
BUSINESSWIRE
12 Jun 2024
Share Share
PTC`s Emflaza to face generics this month post Aurobindo FDA nod

PTC`s Emflaza to face generics this month post Aurobindo FDA nod
FIERCE PHARMA
12 Feb 2024
Share Share
Aurobindo Pharma`s Generic Deflazacort Receives Approval in the U.S.

Aurobindo Pharma`s Generic Deflazacort Receives Approval in the U.S.
FDA
09 Feb 2024
Share Share
Aurobindo`s Generic Deflazacort Receives Approval in the U.S.

Aurobindo`s Generic Deflazacort Receives Approval in the U.S.
FDA
29 Mar 2023
Share Share
Amber Specialty Pharmacy Selected by PTC Therapeutics, Inc. to Dispense EMFLAZA®

Amber Specialty Pharmacy Selected by PTC Therapeutics, Inc. to Dispense EMFLAZA®
BUSINESSWIRE
08 Oct 2020
Share Share
Sarepta now needs flawless progress for gene therapy

Sarepta now needs flawless progress for gene therapy
Jonathan Gardner BIOPHARMADIVE
20 Aug 2019
Share Share
Sarepta’s DMD drug hit with FDA Complete Response Letter

Sarepta’s DMD drug hit with FDA Complete Response Letter
Anna Smith PHARMA TIMES
20 Aug 2019
Share Share
Sarepta Duchenne drug rejected by FDA in surprise setback

Sarepta Duchenne drug rejected by FDA in surprise setback
Jonathan Gardner BIOPHARMADIVE
20 Aug 2019
Share Share
FDA spurns Sarepta’s second Duchenne drug

FDA spurns Sarepta’s second Duchenne drug
Amirah Al Idrus FIERCE BIOTECH
19 Aug 2019
Share Share
ICER blasts FDA, PTC and Sarepta for high prices on DMD Emflaza, Exondys 51

ICER blasts FDA, PTC and Sarepta for high prices on DMD Emflaza, Exondys 51
Amber Tong ENDPTS
17 Aug 2019
Share Share